01/12/2010
ReGen Therapeutics Plc (‘ReGen’) is pleased to announce that it has today signed an agreement with LG Life Sciences, Ltd (‘LGLS’), appointing them as the exclusive distributor of its nutritional supplement ColostrininTM in South Korea.
LGLS is the leading pharmaceutical company based in Seoul, Korea, committed to promoting health and well being of patients and customers. Its key therapeutic areas include metabolic and cardiovascular diseases as well as well-being. In parallel LGLS has a unique capability to develop and market nutraceutical products and has a plan to distribute ColostrininTM through various shopping channels. Additional information is available on its corporate website, http://www.lgls.co.kr/.
This appointment is conditional upon LGLS securing import and regulatory approval for the product. An application to gain approval should be submitted before the end of the first quarter of 2011 but approval may take some considerable time to achieve. LGLS will also be developing their own formulation of ColostrininTM specifically tailored to the retail market in South Korea. No further details of the agreement will be disclosed at this time.
To date ColostrininTM is marketed as a nutritional supplement to ‘support healthy brain aging and cognition in humans’ in the US, Canada, Australia and Poland under the brand name CogniSureTM *, in Cyprus under the brand name CognaseTM **, in the UK under the brand name MemoryAidTM ***, in Turkey under the brand name DynaTM **** and in India under the brand name CognateTM *****
The ReGen Board regards this is a significant step for ReGen as it provides entry into the major growth area of the world economy. It is very important in the context of the accelerated roll out programme for ColostrininTM.
* ColostrininTM for use as a human nutraceutical is licensed in North America and Australasia to Metagenics Inc. of San Clemente, California (http://www.metagenics.com/).
ColostrininTM is distributed in Poland by Tagerr Polska, an affliate of Tagerr a professional services and trading company established in Köln, Germany. (http://www.cognisure.eu/)
** ColostrininTM is distributed in the Republic of Cyprus by Golgi Pharmaceuticals Ltd (http://www.healthybrainaging.com/).
*** ColostrininTM is distributed in the UK by PRG Nutraceuticals Ltd (http://www.memoryaid.com/)
**** ColostrininTM is distributed in Turkey by Eczacibasi Ilac Pazarlama A.S (http://www.eczacibasi.com/)
***** ColostrininTM is distributed in India by USV Ltd (http://www.usvindia.com/)
For further information:
Percy Lomax
ReGen Therapeutics Plc
Tel No 020 7153 4920
Roland Cornish/Felicity Geidt
Beaumont Cornish Limited
Tel No 020 7628 3396
Nick Bealer/David Scott
Alexander David
Tel No 020 7448 9820